Laurus Labs Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹1,778.29 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7.55 per cent from ₹1,653.47 crore. This corresponds to a year-on-year *(YoY) growth of 25.67 per cent.
Operating Profit
Operating Profit stands at ₹44.55 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 33.47 per cent from ₹66.96 crore. This corresponds to a year-on-year *(YoY) decline of 33.73 per cent.
PBDT
PBDT stands at ₹194.07 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1.22 per cent from ₹196.47 crore. This corresponds to a year-on-year *(YoY) growth of 32.78 per cent.
Profit Before Tax
Profit Before Tax stands at ₹325.33 crore, reflecting a quarter-on-quarter *(QoQ) increase of 20.28 per cent from ₹270.47 crore. This corresponds to a year-on-year *(YoY) growth of 144.59 per cent.
Net Profit
Net Profit stands at ₹251.66 crore, reflecting a quarter-on-quarter *(QoQ) increase of 29.08 per cent from ₹194.97 crore. This represents a 172.65 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Laurus Labs Ltd News
Laurus Labs Ltd Earnings
- YOY
- QOQ
Laurus Labs Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Laurus Labs Ltd Research Reports
Laurus Labs Ltd Financial Reports
Laurus Labs Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Laurus Labs | -0.19% | 0.38% | 1.79% | 3.76% | 16.55% | 89.32% |
| Biocon | 1.00% | 2.19% | 6.17% | -1.74% | 7.74% | 20.85% |
| Glenmark Pharma. | -0.35% | -0.10% | 1.76% | 10.61% | 4.12% | 53.64% |
| Abbott India | 0.52% | -0.38% | -4.64% | -11.18% | -16.26% | -11.47% |
| Glaxosmi. Pharma | 1.28% | 1.06% | 12.58% | 6.40% | -5.92% | 0.07% |
| Anthem Bioscienc | 2.32% | 0.51% | 17.63% | 10.24% | -17.38% | -4.64% |
| Ipca Labs. | 1.85% | -1.06% | 1.59% | 3.96% | 5.51% | 2.68% |
Company Info
Company Information
Executive Director & CEO : CHAVA SATYANARAYANA
Executive Director & CFO : VENKATA RAVI KUMAR VANTARAM
Executive Director : Chandrakanth Chereddi
Director : Narendra Ostawal
Independent Director : Aruna Bhinge
Independent Director : Rajesh Koshy Chandy
Independent Director : Ramesh Subrahmanian
Company Secretary : G Venkateswar Reddy
Chairman : M Venu Gopala Rao
Independent Director : Ravindranath Kancherla
Executive Director : Venkata Lakshmana Rao Chunduru